Purification of a Therapeutic Protein

Purification of a Therapeutic Protein

In this simulation, you will design a protein purification experiment that could be used to purify a therapeutic protein. Here, we use a monoclonal antibody as an example of a therapeutic protein.

Topics

  • ALXCollab
  • A280
  • AEX
  • affinity chromatography
  • anion-exchange chromatography
  • antibody structure
  • antigen
  • bind and elute
  • capture
  • cation-exchange chromatography
  • cell-based impurity
  • centrifugation
  • CEX
  • chromatography
  • clarification
  • clarified supernatant
  • column chromatography
  • drug substance process development
  • drug substance technology
  • drug substance
  • eluate
  • eluent
  • flowthrough
  • fraction number
  • fraction
  • fractionation
  • HIC
  • host cell
  • hydrophobic interaction chromatography
  • hydrophobic
  • IEX
  • impurity
  • ion-exchange chromatography
  • isoelectric point
  • ligand
  • mAb structure
  • mAb variant
  • mAb
  • mobile phase
  • monoclonal antibody
  • pellet
  • percent yield
  • pI
  • polishing 1
  • polishing 2
  • polishing
  • process development
  • process-related impurity
  • product-related impurity
  • protein A affinity chromatography
  • protein A
  • protein G
  • protein gel electrophoresis
  • protein of interest
  • protein purification
  • purification buffer
  • purification
  • purified mAb
  • purified protein
  • purity
  • resin
  • SDS-PAGE
  • SDS-PAGE gel
  • SEC
  • size-based filtration
  • size-exclusion chromatography
  • stained SDS-PAGE gel
  • stationary phase
  • supernatant
  • therapeutic mAb
  • therapeutic monoclonal antibody
  • therapeutic protein
  • UV chromatogram
  • yield